Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA85A TB vaccine in children and infants
NCT00679159Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Feb 2008
- Primary completion
- Dec 2009
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of MVA85A in Tuberculosis (TB), sponsored by University of Oxford. Started Feb 2008; status: completed.
02
Drugs
MVA85A
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00679159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679159.